Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Choose oral contraceptives with specific side effects to manage issues like acne and avoid unwanted effects.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Letrozole reduces seizures but not brain damage in mice.

11-oxyandrogens are linked to excess hair growth in PCOS, but don't help diagnose it.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Aromatase inhibitors cause male pattern hair loss in women.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Allopregnanolone changes gene expression in glioblastoma cells.

A rare ovarian tumor in a 2-year-old girl was successfully removed, normalizing her hormone levels.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.